The Vanguard Group 13D and 13G filings for Nektar Therapeutics:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:09 pm Sale | 2023-12-29 | 13G | Nektar Therapeutics NKTR | The Vanguard Group | 802,858 6.310% | -888 (-0.11%) | Filing |
| 2023-07-10 10:41 am Sale | 2023-06-30 | 13G | Nektar Therapeutics NKTR | The Vanguard Group | 803,746 6.370% | -733,973 (-47.73%) | Filing |
| 2023-02-09 11:27 am Purchase | 2022-12-30 | 13G | Nektar Therapeutics NKTR | The Vanguard Group | 1,537,718 12.270% | 303,591 (+24.60%) | Filing |
| 2022-01-10 11:49 am Purchase | 2021-12-31 | 13G | Nektar Therapeutics NKTR | The Vanguard Group | 1,234,127 10.030% | 149,288 (+13.76%) | Filing |
| 2021-02-10 11:28 am Purchase | 2020-12-31 | 13G | Nektar Therapeutics NKTR | The Vanguard Group | 1,084,839 9.070% | 7,665 (+0.71%) | Filing |